Search Results 341-350 of 14732 for anti-TNF drugs

1. Infectious diseases - Diagnosis & treatment - Mayo Clinic

   More-severe internal organ fungal infections, especially in people with weakened immune systems, may require intravenous antifungal medications. Anti-parasitics.

2. Anti-Inhibitor Coagulant Complex (Intravenous Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. A doctor or other trained health professional will give you this medicine.

3. Diphtheria Antitoxin (Injection Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Focus Areas - Rheumatology - Mayo Clinic Research

   ... anti-rheumatic medication selection for patients with rheumatoid arthritis. Medications are tailored to individual patients based on their genomic, clinical ...

5. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

   This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.

6. Drug addiction (substance use disorder) - Care at Mayo Clinic

   Drug addiction affects your brain and behavior to the point where you can't control your use of legal or illegal drugs, even when you know they cause harm.

7. Thalidomide (Oral Route) Description and Brand Names - Mayo Clinic

   This medicine is also used to treat moderate to severe new lesions of leprosy and as maintenance treatment to prevent and keep erythema nodosum leprosum (skin ...

8. Ruxolitinib (Topical Application Route) Precautions - Mayo Clinic

   This medicine may increase the level of cholesterol and fat in your blood. Talk to your doctor if you have concerns. Do not take other medicines unless they ...

9. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

   Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

10. Cancer treatment myths: Any truth to these common beliefs? - Mayo Clinic

    This may lead to the cancer cells no longer responding to the chemotherapy drugs or radiation treatments that were given initially. Myth: Drug companies and the ...